Effect of estrogen treatment and vitamin D status on differing bioavailabilities of calcium carbonate and calcium citrate

Journal of Clinical Pharmacology

Volumn 42, Issue 11, 2002, Pages 1251-1256

  Heller, Howard J ^a,b,c   Poindexter, John R ^c   Adams Huet, Beverley ^b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM CARBONATE; CITRATE CALCIUM; ESTROGEN; PLACEBO; VITAMIN D;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL AVAILABILITY; CALCIUM; CALCIUM CARBONATE; CALCIUM CITRATE; CROSS-OVER STUDIES; DRUG COMBINATIONS; DRUG INTERACTIONS; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; VITAMIN D;

EID: 0036839152     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127002762491343     Document Type: Article

References (25)

1. Lips P: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501.
2. Bryant RJ, Cadogan J, Weaver CM: The new dietary reference intakes for calcium: Implications for osteoporosis. J Am Coll Nutr 1999;18(suppl.):406S-412S.
3. Heaney RP, Recker RR, Saville PD: Menopausal changes in calcium balance performance. J Lab Clin Med 1978;92:953-963.
4. Institute of Medicine: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1997.
5. Recker RR: Calcium absorption and achlorhydria. N Engl J Med 1985;313:70-73.
6. Heller HL, Greer LG, Haynes SD, Poindexter JR, Pak CYC: Pharmacokinetic and pharmacodynamic comparison of two calcium supplements in postmenopausal women. J Clin Pharmacol 2000;40:1237-1244.
7. Heaney RP, Dowell MS, Barger-Lux MJ: Absorption of calcium as the carbonate and citrate salts, with some observations on method. Osteoporos Int 1999;9:19-23.
8. Heaney RP, Dowell MS, Bierman J, Hale CA, Bendich A: Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 2001;20:239-246.
9. Schwarz M, Lund EG, Setchell DR, et al: Disruption of cholesterol 7α-hydroxylase gene in mice. J Biol Chem 1996;271:18024-18031.
10. Reinhardt TA, Horst RL, Orr TW, Hollis BW: A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: Application to clinical studies. J Clin Endocrinol Metab 1984;58:91-98.
11. Watanabe Y, Kubota T, Suzumura E, et al: 1,25-dihydroxyvitamin D radioreceptor assay using bovine mammary gland receptor and non-high performance liquid chromatographic purification. Clin Chim Acta 1994;225:187-194.
12. Grodstein F, Stampfer MJ, Manson JE, et al: Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
13. Aguado P, del Campo MT, Garcés ML, et al: Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: Their relationship with bone mineral density. Osteoporos Int 2000;11:739-744.
14. Wasserman RH, Fullmer CS: Vitamin D and intestinal calcium transport: Facts, speculations and hypotheses. J Nutr 1995;125(suppl.):1971S-1979S.
15. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF: Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 1997;82:4111-4116.
16. Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF: An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 1995;80:406-411.
17. 3 therapy in postmenopausal osteoporosis: Demonstration of responsive and non-responsive subgroups. J Clin Endo Metab 1983;56:410-413.
18. Riggs BL, Khosla S, Melton LJ III: A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763-773.
19. 3 in oophorectomized women. J Clin Endo Metab 1990;71:1288-1293.
20. Bolscher MT, Netelenbos JC, Barto R, Van Buuren LM, Van der Vijgh WJF: Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat. J Bone Miner Res 1999;14:1197-1202.
21. 3-independent stimulatory effect of estrogen on the expression of ECaC1 in the kidney. J Am Soc Nephrol 2002;13:2102-2109.
22. Pak CYC, Poindexter J, Finlayson B: A model system for assessing physicochemical factors affecting calcium absorbability from the intestinal tract. J Bone Min Res 1989;4:119-127.
23. Favus MJ, Pak C: Evidence for absorption of ionic calcium and soluble calcium complexes by the duodenum and cecum in the rat. Am J Ther 2001;8:425-431.
24. Cai Q, Chandler JS, Wasserman RH, Kumar R, Penniston JT: Vitamin D and adaptation to dietary calcium and phosphate deficiencies increase intestinal plasma membrane calcium pump gene expression. Proc Natl Acad Sci USA 1993;90:1345-1349.
25. Daugirdas JT, Arrieta J, Ye M, Flores G, Battle DC: Intracellular acidification associated with changes in free cytosolic calcium: Evidence for Ca2+/H+ exchange via a plasma membrane Ca(2+)-ATPase in vascular smooth muscle cells. J CIin Invest 1995;95:1480-1489.